Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts

Molecular Immunology

Volumn 52, Issue 1, 2012, Pages 38-49

  Die, Liu ^a   Yan, Peng ^a   Jun Jiang, Zhai ^a   Min Hua, Teng ^a   Cai, Wen ^a   Xing, Liang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Beta catenin; CD40; Glycogen synthase kinase 3 beta; Lipopolysaccharide; Nuclear factor kappa B; Osteoblast

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BACTERIUM LIPOPOLYSACCHARIDE; BETA CATENIN; CD40 ANTIGEN; DNA; GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BONE DISEASE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOPRECIPITATION; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; OSTEOBLAST; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; ANTIGENS, CD40; BASE SEQUENCE; BETA CATENIN; CYTOKINES; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; IMMUNOSUPPRESSIVE AGENTS; INDOLES; LIPOPOLYSACCHARIDES; MALEIMIDES; MICE; NF-KAPPA B; OSTEOBLASTS; PORPHYROMONAS GINGIVALIS; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; WNT SIGNALING PATHWAY;

BACTERIA (MICROORGANISMS); MURINAE; PORPHYROMONAS GINGIVALIS;

EID: 84860822029     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.04.005     Document Type: Article

References (74)

1. Ahuja S.S., Zhao S., Bellido T., Plotkin L.I., Jimmenez F., Bonewald L.F. CD40 ligand blocks apoptosis induced by tumor necrosis factor α, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 2003, 144:1761-1769.
2. Alderson M.R., Armitage R.J., Tough T.W., Strokbine L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. Journal of Experimental Medicine 1993, 178:669-674.
3. Amano A. Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease. Journal of Periodontology 2003, 4:90-96.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Bandow K., Maeda A., Kakimoto K., Kusuyama J., Shamoto M., Ohoishi T., Matsuguchi T. Molecular mechanisms of the inhibitory effect of Lippolysaccharide (LPS) on osteoblast differentiation. Biochemical and Biophysical Research Communications 2010, 402:755-761.
6. Benveniste E.N., Nguyen V.T., Wesemann D.R. Molecular regulation of CD40 gene expression in macropahges and microglia. Brain, Behavior, and Immunity 2004, 18:7-12.
7. Bergmann C., Akhmetshina A., Dees C., Palumbo K., Zerr P., Beyer C., Zwerina J., Dister O., Schett G., Distler J.H.W. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Annals of the Rheumatic Diseases 2011, 70:2191-2198.
8. Beurel E., Jope R.S. Glycogen synthase kinase-3 promotes the synergistic action of interferon-gamma on lipopolysaccharide-induced IL-6 production in RAW264.7 cells. Cellular Signaling 2009, 21:978-985.
9. Beurel E., Michalek S.M., Jope R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends in Immunology 2010, 31:24-31.
10. Bonizzi G., Karin M. The two NF-kappa B activation pathways and their role in innate and adaptive immunity. Trends in Immunology 2004, 25:280-288.
11. Coghlan M.P., Culbert A.A., Cross D.A., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Roxbee C.L., Millis D., Brown M.J., Haigh D., Ward R.W., Smith D.G., Murray K.L., Reith A.D., Holder J.C. Selective small molecule inhibitor of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chemistry and Biology 2000, 7:793-803.
12. D'Alimonte I., Flati V., D'Auro M., Toniato E., Martinotti S., Rathbone M.P., Jiang S., Ballerini P., Di Iorio P., Caciagli F., Ciccarelli R. Guanosine inhibits CD40 receptor expression and function induced by cytokines and beta amyloid in mouse microglia cells. Journal of Immunology 2007, 178:720-731.
13. Deng J., Miller S.A., Wang H.Y., Xia W., Wen Y., Zhou B.P., Li Y., Lin S.Y., Huang M.C. β-Catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell 2002, 2:323-334.
14. Deng J., Xia W., Miller S.A., Wen Y., Wang H.Y., Huang M.C. Crossregulation of NF-κB by the APC/GSK-3β/β-catenin pathway. Molecular Carcinogenesis 2004, 39:139-146.
15. Diehl L., Den Boer A.T., van der Voort E.I., Melief C.J., Offringa R., Toes R.F. The role of CD40 in peripheral T cell tolerance and immunity. Journal of Molecular Medicine 2000, 78:363-371.
16. Du Q., Zhang X., Cardinal J., Cao Z., Guo Z., Shao L., Geller D.A. Wnt/β-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-κB activation in cancer cells. Cancer Research 2009, 69:3764-3771.
17. Duan Y., Liao A.P., Kuppireddi S., Ye Z., Ciancio M.J., Sun J. β-Catenin activity negatively regulates bacteria-induced inflammation. Laboratory Investigation 2007, 87:613-624.
18. Dugo L., Collin M., Thiememann C. Glycogen synthase kinase 3β as a target for the therapy of shock and inflammation. Shock 2007, 27:113-123.
19. Freese J.L., Pino D., Pleasue S.J. Wnt signaling in development and disease. Neurobiology of Disease 2010, 38:148-153.
20. Gao H.K., Yin Z., Zhou N., Feng X.Y., Gao F., Wang H.C. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apopotosis. Journal of Cardiovascular Pharmacology 2008, 52:286-292.
21. Gelbmann C.M., Leeb S.N., Vogl D., Maendel M., Herfarth H., Scholmerich J., Falk W., Rogler G. Inducible CD40 expression mediates NF-κB activation and cytokine secretion in human colonic fibroblasts. Gut 2003, 52:1448-1456.
22. Gurrieri C., Piazza F., Gnoato M., Montini B., Biasutto L., Gattazzo C., Brunetta E., Cabrelle A., Cinetto F., Niero R., Facco M., Garbisa S., Calabrese F., Semezato G., Agostini C. 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB21673), a glycogen synthase kinase-3 inhibitor, displays therapeutic proterties in a mouse model of pulmonary inflammation and fibrosis. Journal of Pharmacology and Experimental Therapeutics 2010, 332:785-794.
23. Harhaj E.W., Harhaj N.S., Grant C., Mostoller K., Alefantis T., Sun S.C., Wigdahl B. Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappa B pathway. Virology 2005, 333:145-158.
24. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappa B activation. Nature 2000, 406:86-90.
25. Hultin M., Gustafsson A., Hallstrom H., Johansson L.A., Ekfeldt A., Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clinical Oral Implants Research 2002, 13:349-358.
26. Javed F., Al-Hezaimi K., Salameh Z., Almas K., Romanos G.E. Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytokine 2011, 53:8-12.
27. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 2004, 29:95-102.
28. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. Journal of Immunology 1995, 155:4917-4925.
29. Kornbluth R.S., Kee K., Richman D.D. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5205-5210.
30. Kubota T., Michigami T., Ozono K. Wnt signaling in bone metabolism. Journal of Bone and Mineral Metabolism 2009, 27:265-271.
31. Kulkarni N.H., Onyia J.E., Zeng Q., Tian X., Liu M., Halladay D.L., Frolik C.A., Engler T., Wei T., Kriauciunas A., Martin T.J., Sato M., Bryant H.U., Ma Y.L. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. Journal of Bone and Mineral Research 2006, 21:910-920.
32. Lam Q.L.K., Zheng B.J., Jin D.Y., Cao X.T., Lu L.W. Leptin induces CD40 expression through the activation of Akt in murine dentritic cells. Journal of Biological Chemistry 2007, 282:27587-27597.
33. Lee H.L., Yi T., Woo K.M., Ryoo H.M., Kim G.S., Baek J.H. Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Experimental and Molecular Medicine 2010, 42:437-445.
34. Liang Y., Zhou Y., Shen P. NF-kappa B and its regulation on the immune system. Cellular & Molecular Immunology 2004, 1:343-350.
35. Lin H.W., Levison S.W. Context-dependent IL-6 potentiation of interferon-gamma-induced IL-12 secretion and CD40 expression in murine microglia. Journal of Neurochemistry 2009, 111:808-818.
36. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004, 20:781-810.
37. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
38. Moon R.T., Kohn A.D., De Ferrari G.V., Kaykas A. Wnt and beta-catenin signaling: diseases and therapies. Nature Reviews Genetics 2004, 5:691-701.
39. Mukundan L., Bishop G.A., Head K.Z., Zhang L., Wahl L.M., Suttles J. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. Journal of Immunology 2005, 174:1081-1090.
40. Munroe M.E., Bishop G.A. A costimulatory function for T cell CD 40. Journal of Immunology 2007, 178:671-682.
41. Natsume H., Tokuda H., Adachi S., Matsushima-Nishiwaki R., Kato K., Minamitani C., Otsuka T., Kozawa O. Wnt3a regulates tumor necrosis factor-α-stimulated interleukin-6 release in osteoblasts. Molecular and Cellular Endocrinology 2011, 331:66-72.
42. Noelle R.J. CD40 and its ligand in host defense. Immunity 1996, 4:415-419.
43. Nonnenmacher C., Dalpke A., Rochon J., Flores-de-Jacoby L., Mutters R., Heeg K. Realtime polymerase chain reaction for detection and quantification of bacteria in periondontal patients. Journal of Periodontology 2005, 76:1542-1549.
44. Ohno T., Okahashi N., Kawai S., Kato T., Inaba H., Shibata Y., Morisakin I., Abiko Y., Amano A. Proinflammatory gene expression in mouse ST2 cell line in response to infection by porphyromonas ginvimalis. Microbes and Infection 2006, 8:1025-1034.
45. Ougolkov A.V., Bone N.D., Fernandez-Zapico M.E., Kay N.E., Billadeau D.D. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappa B target gene and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood 2007, 110:735-742.
46. Perez E., Garcia-Martinez O., Arroyo-Morales M., Reyes-Botella C., Ruiz C. Modulation of antigenic phenotype in cultured human osteoblast-like cells by FGFb, TGFβ1, PDGF-BB, IL-2, IL-1β, LPS and IFNγ. Bioscience Reports 2006, 26:281-289.
47. Poggi M., Jager J., Paulmyer-Lacroix O., Peirette F., Gremeaux T., Verdier M., Grino M., Stepanian A., Msika S., Burcelin R., de Prost D., Tanti J.F., Alessi M.C. The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 2009, 52:1152-1163.
48. Qin H.W., Wilson C.A., Lee S.J., Zhao X., Benveniste E.N. LPS induces CD40 gene expression through the activation of NF-kappa B and STAT-1 alpha in macrophages and microglia. Blood 2005, 106:3114-3122.
49. Revy P., Sospedra M., Barbour B., Trautmann A. Functional antigen-independents synapses formed between T cells and dendritic cells. Nature Immunology 2001, 2:925-931.
50. Rezai-Zadeh K., Ehrhart J., Bai Y., Sanberg P.R., Bickford P., Tan J., Shytle R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT-induced CD40 expression. Journal of Neuroinflammation 2008, 5:41.
51. Sanchez J.F., Sniderhan L.F., Williamson A.L., Fan S., Chakraborty-Sett S., Maggirwar S.B. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappa B signaling. Molecular and Cellular Biology 2003, 23:4649-4662.
52. Schrum L.W., Marriott I., Butler B.R., Thomas E.K., Hudson M.C., Bost K.L. Functional CD 40 expression induced following bacterial infection of mouse and human osteoblasts. Infection and Immunity 2003, 71:1209-1216.
53. Schwabe R.F., Brenner D.A. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappa B activation and apoptosis in hepatocyte. American Journal of Physiology-Gastrointestinal and Liver Physiology 2002, 283:G204-G211.
54. Schytte Blix I.J., Helgeland K., Hvattum E., Lyberg T. Lipopolysaccharide form Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagnist in human whole blood. Journal of Periodontal Research 1999, 34:34-40.
55. Singh K., Sinha S., Malonia S.K., Chattopadhyay S. Tumor Necrosis Factor alpha (TNF-α) regulates CD40 expression through SMAR1 phosphorylation. Biochemical and Biophysical Research Communications 2010, 391:1255-1261.
56. Smith D.G., Buffet M., Fenwich A.E., Haigh D., Ife R.J., Saunders M., Slingsby B.P., Stacey R., Ward R.W. 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3(GSK-3). Bioorganic and Medicinal Chemistry Letters 2001, 11:635-639.
57. Sodo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. Journal of Cell Biology 1983, 96:191-198.
58. Song Z.F., Jin R., Yu S.Y., Nanda A., Granger D.N., Li G.H. Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventrions. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32:50-64.
59. Stanley K.T., VanDort C., Motyl C., Endres J., Fox D.A. Immunocompetent properties of human osteoblasts: interactions with T lymphocytes. Journal of Bone and Mineral Research 2006, 21:29-36.
60. Steinbrecher K.A., Wilson W., Cogswell P.C., Baldwin A.S. Glycogen synthase kinase 3β functions to specify gene-specific NF-γB-dependent transcription. Molecular and Cellular Biology 2005, 25:8444-8455.
61. Stout R.D., Suttles J., Xu J.C., Grewal I.S., Flavell R.A. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. Journal of Immunology 1996, 156:8-11.
62. Sun J., Hobert M.E., Duan Y., Rao A.S., He T.C., Chang E.B., Madara J.L. Crosstalk between NF-κB and β-catenin pathways in bacterial-colonized intestinal epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2005, 289:G129-G137.
63. Suttles J., Stout R.D. Macrophage CD40 signaling A pivotal regulator of disease protection and pathogenesis. Seminars in Immunology 2009, 21:257-264.
64. Takada Y., Fang X., Jamaluddin M.S., Boyd D.D., Aggarwal B.B. Genetic depletion of glycogen synthase kinase-3beta abrogates activation of Ikappa-B alpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. Journal of Biological Chemistry 2004, 279:39541-39554.
65. Tone M., Tone Y., Babik J.M., Lin C.Y., Waldmann H. The role of Sp1 and NF-κB in regulating CD40 gene expression. Journal of Biological Chemistry 2002, 277:8890-8897.
66. Verbruggen A., De Clerck L.S., Bridts C.H., Van Offel J.F., Stevens W.J. Flow cytometrical determination of interleukin 1beta, interleukin 6 and tumour ncrosis factor alpha in monocytes of rheumatoid arthritis patients; relation with parameters of osteoporosis. Cytokine 1999, 11:869-874.
67. Wagner D.H., Stout R.D., Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. European Journal of Immunology 1994, 24:3148-3154.
68. Wang F.S., Ko J.Y., Weng L.H., Yeh D.W., Ke H.J., Wu S.L. Inhibition of glycogen synthase kinase-3β attenuates glucocoticoid-induced bone loss. Life Sciences 2009, 85:685-692.
69. Wang Y.H., Jiang J., Zhu Q., AlAnezi A.Z., Clark R.B., Jiang X., Rowe D.W., Nichols F.C. Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function. Infection and Immunity 2010, 78:3726-3735.
70. Westerndrof J.J., Kahler R.A., Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39.
71. Wu J., Yang X., Zhang Y.F., Zhou S.F., Zhang R., Dong X.Q., Fan J.J., Liu M., Yu X.Q. Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells. Inflammation Research 2009, 58:473-482.
72. Xing Q., Ye Q., Fan M., Zhou Y., Xu Q., Sandham A. Porphyromonas gingivalis Lipopolysaccharide inhibits the osteoblastic differentiation of preosteoblasts by activation Notch1 signaling. Journal of Cellular Physiology 2010, 225:106-114.
73. Yavropoulou M.P., Yovos J.G. The role of the Wnt signaling pathway in osteoblast commitment and differentiation. Hormones 2007, 6:279-294.
74. Yuskaitis C.J., Jope R.S. Glycogen synthase kinase-3 regulates microglial migration inflammation, and inflammation-induced neurotoxicity. Cellular Signalling 2009, 21:264-273.